|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001675,
umls-concept:C0007634,
umls-concept:C0009491,
umls-concept:C0022688,
umls-concept:C0039194,
umls-concept:C0041633,
umls-concept:C0085379,
umls-concept:C0086418,
umls-concept:C0162388,
umls-concept:C0205282,
umls-concept:C0205307,
umls-concept:C0229664,
umls-concept:C0441655,
umls-concept:C1533691,
umls-concept:C1579762,
umls-concept:C1879547,
umls-concept:C2350466
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2002-3-6
|
|
pubmed:abstractText |
We aimed to determine the effects of human umbilical cord blood (UCB)-derived natural killer T (NKT) cells as immunological effectors against hematological malignancies, as well as auto- or allo-dendritic cells (DCs) or EB transformed cell lines (EBCLs).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD1,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD1d,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/CD1D protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Galactosylceramides,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-12,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-18,
http://linkedlifedata.com/resource/pubmed/chemical/Muromonab-CD3,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Antigen, T-Cell...
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0340-7004
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
51
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1-8
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:11845254-Antigens, CD1,
pubmed-meshheading:11845254-Antigens, CD1d,
pubmed-meshheading:11845254-Antigens, Neoplasm,
pubmed-meshheading:11845254-Autoimmunity,
pubmed-meshheading:11845254-Blood Cells,
pubmed-meshheading:11845254-Cell Line, Transformed,
pubmed-meshheading:11845254-Cell Separation,
pubmed-meshheading:11845254-Cytotoxicity, Immunologic,
pubmed-meshheading:11845254-Dendritic Cells,
pubmed-meshheading:11845254-Dose-Response Relationship, Drug,
pubmed-meshheading:11845254-Fetal Blood,
pubmed-meshheading:11845254-Flow Cytometry,
pubmed-meshheading:11845254-Galactosylceramides,
pubmed-meshheading:11845254-Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor,
pubmed-meshheading:11845254-Hematologic Neoplasms,
pubmed-meshheading:11845254-Humans,
pubmed-meshheading:11845254-Interleukin-12,
pubmed-meshheading:11845254-Interleukin-18,
pubmed-meshheading:11845254-Killer Cells, Natural,
pubmed-meshheading:11845254-Lymphocyte Activation,
pubmed-meshheading:11845254-Muromonab-CD3,
pubmed-meshheading:11845254-Neoplastic Stem Cells,
pubmed-meshheading:11845254-Receptors, Antigen, T-Cell, alpha-beta,
pubmed-meshheading:11845254-T-Lymphocyte Subsets,
pubmed-meshheading:11845254-Tumor Cells, Cultured
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Killing activity of human umbilical cord blood-derived TCRValpha24(+) NKT cells against normal and malignant hematological cells in vitro: a comparative study with NK cells or OKT3 activated T lymphocytes or with adult peripheral blood NKT cells.
|
|
pubmed:affiliation |
Department of Hematology and Rheumatology, Tokai University School of Medicine, Bohseidai, Isehara, Kanagawa, Japan 259-1193. masaoha@is.icc.u-tokai.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
